SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON D.C. 20549

                                   FORM 10-Q

                  QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                    For the quarter ended September 30, 2010

                         Commission File Number 0-10683

                                 HYDROMER, INC.
                                 --------------
             (Exact name of registrant as specified in its charter)
     New Jersey                                         22-2303576
----------------------                           -------------------------
(State of incorporation)                             (I.R.S. Employer
                                                     Identification No.)

35 Industrial Pkwy, Branchburg, New Jersey                08876-3424
------------------------------------------       -------------------------
  (Address of principal executive offices)                (Zip Code)

Registrant's telephone number, including area code:      (908) 722-5000
                                                     -------------------------

Securities registered pursuant to Section 12 (b) of the Act: None

Securities registered pursuant to Section 12 (g) of the Act:

                         Common Stock Without Par Value
                                (Title of class)

   Indicate  by  check  mark  whether  the  registrant (1) has filed all reports
required  to  be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934  during  the  preceding  12  months  (or  for  such shorter period that the
registrant was required to file such report(s), and (2) has been subject to such
filing requirements for the past 90 days. [X] Yes   [ ] No

   Indicate  by  check mark whether the registrant is a large accelerated filer,
an  accelerated  filer, a non-accelerated filer, or a smaller reporting company.
        Large accelerated filer [ ]             Accelerated filer [ ]
        Non-accelerated filer [ ]               Smaller reporting company [X]

   Indicate  by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act).

Yes [ ]   No [X]

                Class                          Outstanding at September 30, 2010
                -----                          ---------------------------------
               Common                                       4,772,318

--------------------------------------------------------------------------------

                           FORWARD-LOOKING STATEMENTS

This  quarterly  report  on Form 10-Q contains forward-looking statements within
the  meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Forward-looking statements include, among other
things,  business  strategy  and  expectations  concerning  industry conditions,
market  position,  future  operations,  margins,  profitability,  liquidity  and
capital resources. Forward-looking statements generally can be identified by the
use  of  terminology  such  as  "may,"  "will,"  "expect," "intend," "estimate,"
"anticipate" or "believe" or similar expressions or the negatives thereof. These
expectations  are based on management's assumptions and current beliefs based on
currently   available  information.  Although  the  Company  believes  that  the
expectations  reflected  in  such  statements  are  reasonable,  it  can give no
assurance that such expectations will be correct. You are cautioned not to place
undue  reliance  on these forward-looking statements, which speak only as of the
date  of  this  quarterly  report on Form 10-Q and the Company does not have any
obligation  to  update  the forward looking statements. The Company's operations
are  subject  to  a number of uncertainties, risks and other influences, many of
which  are outside its control, and any one of which, or a combination of which,
could  cause  its  actual  results  of  operations to differ materially from the
forward-looking statements.
                                       1
<PAGE>


                                 HYDROMER, INC.

                               INDEX TO FORM 10-Q
                               September 30, 2010

                                                                        Page No.
Part I  -  Financial Information

      # 1 Consolidated Financial Statements

             Balance Sheets - September 30, 2010 & June 30, 2010           3

             Statements of Operations for the three months ended           4
                 September 30, 2010 and 2009

      Statements of Cash Flows for the three months ended

                 September 30, 2010 and 2009                               5

             Notes to Financial Statements                                 6

      # 2  Management's Discussion and Analysis of the Financial
                 Condition and Results of Operations                       7

      # 3  Controls and Procedures                                         9


Part II  -  Other Information

      # 1  Legal Proceedings                                             N/A

      # 2  Change in Securities                                          N/A

      # 3  Default of Senior Securities                                  N/A

      # 4  Submission of Motion to Vote of Security Holders              N/A

      # 5  Other Information                                             N/A

      # 6  Exhibits                                                        9


                                      EXHIBIT INDEX

Exhibit No.      Description of Exhibit
-----------      ----------------------
31.1             SEC Section 302 Certification - CEO certification        10
31.2             SEC Section 302 Certification - CFO certification        11

32.1             Certification of Manfred F. Dyck, Chief Executive
                         Officer, pursuant to 18 U.S.C. Section 1350      12

32.2             Certification of Robert Y. Lee, Chief Financial
                         Officer, pursuant to 18 U.S.C. Section 1350      12





















                                       2
<PAGE>
PART I - CONSOLIDATED FINANCIAL STATEMENTS
ITEM # 1

<TABLE>
<S>                                                                         <C>               <C>
                                        HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
                                               CONSOLIDATED BALANCE SHEETS


                                                                            September 30,     June 30,

                                                                            2010              2010

                                                                            UNAUDITED         AUDITED
      ASSETS
      Current Assets:
          Cash and cash equivalents                                          $       967,109   $       843,610
          Short-term investments                                                       -               440,000
          Trade receivables  less  allowance  for  doubtful  accounts  of
               $31,817 and $33,276 as  of September 30, 2010 and June 30,            856,690           920,252
               2010, respectively
          Inventory                                                                  326,642           248,569
          Prepaid expenses                                                           166,178           227,338
          Other                                                                        3,236            15,487
      ----------------------------------------------------------------------------------------------------------
      Total Current Assets                                                         2,319,855         2,695,256
      ----------------------------------------------------------------------------------------------------------

      Property and equipment, net                                                  2,979,151         2,988,536
      Deferred tax asset, non-current                                              1,176,873         1,011,945
      Intangible assets, net                                                         852,888           839,722
      ----------------------------------------------------------------------------------------------------------
      Total Assets                                                           $     7,328,767   $     7,535,459
      ----------------------------------------------------------------------------------------------------------

      LIABILITIES AND STOCKHOLDERS' EQUITY
      Current Liabilities:
          Accounts payable                                                   $       330,976   $       342,030
          Accrued expenses                                                           303,530           251,276
          Current portion of capital lease                                            16,407            16,000
          Current portion of deferred revenue                                         95,547            75,828
          Current portion of mortgage payable                                         49,547            48,800
      ----------------------------------------------------------------------------------------------------------
      Total Current Liabilities                                                      796,007           733,934
      ----------------------------------------------------------------------------------------------------------
      Deferred tax liability                                                         318,375           318,375
      Long-term portion of capital lease                                              30,106            34,716
      Long-term portion of deferred revenue                                          169,461           165,813
      Long-term portion of mortgage payable                                        2,756,182         2,769,036
      ----------------------------------------------------------------------------------------------------------
      Total Liabilities                                                            4,070,131         4,021,874
      ----------------------------------------------------------------------------------------------------------

      Stockholders' Equity
          Preferred stock - no par value, authorized 1,000,000 shares, no
             shares issued and outstanding                                            -                 -
          Common stock - no par value, authorized 15,000,000 shares;
               4,783,235 shares issued and 4,772,318 shares outstanding as
               of September 30, 2010 and June 30, 2010                             3,721,815         3,721,815
          Contributed capital                                                        633,150           633,150
          Accumulated deficit                                                     (1,090,189)         (835,240)
          Treasury stock, 10,917 common shares at cost                                (6,140)           (6,140)
      ----------------------------------------------------------------------------------------------------------
      Total Stockholders' Equity                                                   3,258,636         3,513,585
      ----------------------------------------------------------------------------------------------------------
      Total Liabilities and Stockholders' Equity                             $     7,328,767   $     7,535,459
      ----------------------------------------------------------------------------------------------------------

                                                  See accompanying notes
</TABLE>







                                       3
<PAGE>

<TABLE>
                        <S>                                              <C>            <C>

                                        HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
                                          CONSOLIDATED STATEMENTS OF OPERATIONS




                                                                           Three Months Ended
                                                                              September 30,
                                                                           2010            2009
                                                                        UNAUDITED       UNAUDITED
                    ------------------------------------------------   -----------------------------
                    REVENUES
                        Sale of products                             $     650,404   $   1,181,704
                        Service revenues                                   369,321         299,792
                        Royalties and contract revenues                    236,167         228,075
                    ------------------------------------------------   -----------------------------
                        TOTAL REVENUES
                                                                         1,255,892       1,709,571
                    ------------------------------------------------   -----------------------------

                    EXPENSES
                       Cost of Sales                                       426,599         840,194
                       Operating Expenses                                1,199,292       1,266,360
                       Other Expenses                                       49,879          51,614
                       Benefit from Income Taxes                          (164,928)       (176,209)
                    ------------------------------------------------   -----------------------------
                                                                         1,510,842       1,981,959
                             TOTAL EXPENSES
                    ------------------------------------------------   -----------------------------

                             NET LOSS                                $    (254,950)  $    (272,388)
                    ------------------------------------------------   -----------------------------

                             Loss Per Common Share                   $       (0.05)  $       (0.06)

                         Weighted Average Number of
                             Common Shares Outstanding                    4,772,318       4,772,318


                                                 See accompanying notes.

                   There was no impact to earnings per share from dilutive securities as the resultant
                        would have been anti-dilutive.
</TABLE>





























                                       4
<PAGE>

<TABLE>
<S>                                                                                     <C>     <C>
                                        HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
                                          CONSOLIDATED STATEMENTS OF CASH FLOWS



                                                                                       Three months Ended
                                                                                         September 30,
                                                                                     2010            2009
                                                                                   UNAUDITED      UNAUDITED
         -----------------------------------------------------------------------------------------------------
         CASH FLOWS FROM OPERATING ACTIVITIES:
             Net Loss                                                          $    (254,950)  $    (272,388)
         Adjustments to reconcile net loss to net cash in for
             operating activities
                Depreciation and amortization                                        101,244         101,428
                Deferred income taxes                                               (164,928)       (177,564)
                Changes in Assets and Liabilities:
                  Trade receivables                                                   63,562         (22,970)
                  Inventory                                                          (78,073)         (5,370)
                  Prepaid expenses                                                    41,790          42,932
                  Other assets                                                        12,398             414
                  Accounts payable and accrued liabilities                            41,200          49,914
                  Deferred income                                                     23,367           9,968
                  Income taxes payable                                                  -            (60,000)
         -----------------------------------------------------------------------------------------------------

                      Net Cash Used in Operating Activities                         (214,390)       (333,636)

         -----------------------------------------------------------------------------------------------------

         CASH FLOWS FROM INVESTING ACTIVITIES:
             Cash purchases of property and equipment                                (46,896)        (65,010)
             Cash payments on patents and trademarks                                 (43,108)        (83,207)
             Redemption of matured short-term investments                            440,000         260,000
             Cash purchases of short-term investments                                   -           (250,000)
         -----------------------------------------------------------------------------------------------------

                      Net Cash Provided by (Used in) Investing Activities            349,996        (138,217)

         -----------------------------------------------------------------------------------------------------
         CASH FLOWS FROM FINANCING ACTIVITIES:
             Repayment of long-term borrowings                                       (12,107)        (11,276)
         -----------------------------------------------------------------------------------------------------

                      Net Cash Used in Financing Activities                          (12,107)        (11,276)

         -----------------------------------------------------------------------------------------------------
         NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:                       123,499        (483,129)
         Cash and Cash Equivalents at Beginning of Period                            843,610       1,585,765
         -----------------------------------------------------------------------------------------------------

         Cash and Cash Equivalents at End of Period                            $     967,109   $   1,102,636
         -----------------------------------------------------------------------------------------------------



                                                 See accompanying notes.

</TABLE>















                                       5
<PAGE>

                   HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY

                   Notes to Consolidated Financial Statements

In  the  opinion  of management, the accompanying unaudited financial statements
include  all adjustments (consisting of only normal adjustments) necessary for a
fair   presentation   of   the   results   for   the  interim  periods.  Certain
reclassifications  have  been  made  to  the  previous year's results to present
comparable financial statements.

Fair Value:
Some  of the Company's financial instruments are not measured at fair value on a
recurring  basis  but are recorded at amounts that approximate fair value due to
their   liquid  or  short-term  nature,  such  as  cash  and  cash  equivalents,
receivables and payables. The carrying amount of the mortgage is consistent with
the terms available in the market for instruments with similar risk.

Segment Reporting:
The  Company  operates  two primary business segments. The Company evaluates the
segments  by  revenues,  total  expenses  and  earnings  before taxes. Corporate
Overhead  (primarily  the  salaries  and  benefits of senior management, support
services  (Accounting,  Legal,  Human Resources and Purchasing) and other shared
services  (building  maintenance  and warehousing) is excluded from the business
segments  as to not distort the contribution of each segment. These segments are
the  lowest  levels for which identifiable cash flows are largely independent of
the cash flows of other assets and liabilities.

The results for the three months ended September 30, by segment are:

<TABLE>
<S>                      <C>            <C>             <C>             <C>

                        Polymer         Medical         Corporate
                        Research        Products        Overhead        Total
2010
Revenues                $   921,326     $   334,566                     $   1,255,892
Expenses                   (980,130)       (246,837)    $   (448,803)      (1,675,770)
                        -----------     -----------     ------------    -------------
  Pre-tax Income (Loss) $   (58,804)    $    87,729     $   (448,803)   $    (419,878)
                        ===========     ===========     ============    =============

2009
Revenues                $   962,136     $   747,435                     $    1,709,571
Expenses                   (966,814)       (788,962)    $   (402,392)       (2,158,168)
                        -----------     -----------     ------------    -------------
  Pre-tax Income (Loss) $    (4,678)    $   (41,527)    $   (402,392)   $     (448,597)
                        ===========     ===========     ============    =============
</TABLE>






Geographic revenues were as follows for the three months ended September 30,

                                                             2010      2009
                                                             ----      ----
                                 Domestic                     64%       76%
                                 Foreign                      36%       24%
















                                       6
<PAGE>
ITEM #2

                  MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE
                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations

The Company's revenues for the quarter ended September 30, 2010 were $1,255,892,
$453,679  or  26.5%  lower  than the $1,709,571 for the same period the previous
year.  Revenues  are  comprised of the sale of Products and Services and Royalty
and Contract payments.

      Product  sales  were  $650,404 for the quarter ended September 30, 2010 as
      compared  to  $1,181,704  for  the same period the year before, a $531,300
      (45.0%)  decrease; lower due to the impact from the sales of product lines
      to Merit Medical Systems, Inc. ("Merit") in February 2009 and to Forefront
      Medical Technology (PTE) LTD ("Forefront") in November 2009. Including the
      transition  period  in  which  we continued to manufacture products on the
      behalf  of  Merit  and  Forefront  until  October  2009  and  April  2010,
      respectively,  the  product  lines  sold accounted for $515,845 of product
      sales during the quarter ended September 30, 2009. We expect revenues from
      our recently launched Dragonhyde(R) Hoof Bath Concentrates ("HBC") product
      to  more  than  replace  the lost revenues from the sold OEM product lines
      later in calendar 2011.

      Services  revenues  for  the  three  months  ended  September 30, 2010 was
      $369,321  or  $69,529  higher  (23.2%) than the $299,792 the corresponding
      period  the  year  before. Increased demand for our services accounted for
      the increase.

      Royalty  and Contract revenues include royalties received and the periodic
      recurring  payments  from  license,  stand  still and other agreements for
      other than product and services. Included in Royalty and Contract revenues
      are revenues from support and supply agreements. Some of the royalties and
      support  fees  are  based on the net sales of the final item (to which the
      Hydromer technology is applied to) and are subject to the reporting of our
      customers.  For the quarter ended September 30, 2010, Royalty and Contract
      revenues  were  $236,167, compared to $228,075 the same period a year ago.
      It is anticipated that this revenue line will at least double within a few
      years  as a result of one of our hydrogel technologies that has been under
      testing the past few years.

      In  summary, we are at a conversion period on our revenue mix, moving away
      from  the  lower margin OEM product lines that were sold, to the T-HEXX(R)
      Animal Health product line that we have been enriching the past few years,
      including with the Dragonhyde HBC developed and launched recently.

Total  Expenses  for  the  quarter  ended  September 30, 2010 were $1,510,842 as
compared with $1,981,959 the year before, a 23.8% decrease.

      For the quarter ended September 30, 2010, the Company's Cost of Goods Sold
      was  $426,599  as compared with $840,194 the year prior, lower by $413,595
      or 49.2%. The Cost of Goods Sold attributed to the sold product lines were
      approximately $424,000 in the September 2009 quarter.

      Operating  expenses  were  $1,199,292  for the quarter ended September 30,
      2010  as  compared  with  $1,266,360  the year before, lower by $67,068 or
      5.3%.  We  expect  Operating  expenses to not change dramatically from its
      current  level  with  increases  anticipated  for marketing and promotions
      activity,  primarily  from the increased focus in our T-HEXX Animal Health
      business,  including  added international tradeshow promotions and related
      travel and marketing expenditures, offset by other reductions in operating
      expenses  (including reduced patent funding on a cash basis, but not on an
      amortization basis).

      Interest  expense,  interest income and other income are included in Other
      Expenses.  Interest  expense  (on the mortgage) for the three months ended
      September  30,  2010  and  September  30,  2009  were $51,679 and $53,035,
      respectively.

A  net  loss  of  $254,950  ($0.05  per share) is reported for the quarter ended
September  30,  2010 as compared to a net loss of $272,388 ($0.06 per share) the
year before.

      The  sale  of  the  OEM  product  lines had a direct impact to our current
      year's  results by at least $91,000 (reduced revenues less direct costs of

                                       7
<PAGE>
      sales).  Thus  when  adjusting  for the sold OEM product lines, there is a
      greater improvement to the operations this year.

Financial Condition

Working  capital  decreased $437,474 during the three months ended September 30,
2010.

Net  operating  activities  used  $214,390  during  the three month period ended
September 30, 2010.

      The  net  loss,  as  adjusted  for  non-cash  expenses of depreciation and
      amortization  and  deferred  income  taxes, used $318,634 in cash. The net
      change  in other operating assets and liabilities provided for $104,244 in
      cash,  primarily  from  the  collection  of trade receivables, increase in
      accrued  liabilities  and  expensing  of  prepaid expenses as offset by an
      inventory buildup related to the Dragonhyde HBC product launch.

Investing  activities  provided  $349,996  and financing activities used $12,107
during the three months ended September 30, 2010.

      Investing  activities  for  the  three  months  ended  September  30, 2010
      included   $46,896  for  capital  expenditures  and  $43,108  towards  the
      Company's  patent  estate.  $440,000 in short-term investments matured and
      was converted into cash. The Financing activities was the repayment of the
      principal portion of the mortgage.

Over the next few years, if not this fiscal year alone, we expect the demand for
the  T-HEXX  product  lines  to  increase,  replacing  the  lost income from the
cancellation  of the $100,000 per month Supply and Support Agreement (in January
2009  and  replaced with a $35,000 per month agreement) and from the sale of OEM
product  lines.  For  example, replacement revenues coming from the sales of the
recently  introduced  Dragonhyde  HBC  product,  which  is  cost  comparative to
competing  Copper  Sulfate  and much more environmentally and user friendly than
formalin  (formaldehyde).  In addition, there are other new or increased revenue
channels foreseen, including that from its anti-microbial, anti-thrombogenic and
cell  mitosis technologies, however those are further downstream and there is no
assurance  these  future expectations will occur. Nonetheless, the Company has a
strong balance sheet to meet its required debt servicing.






































                                       8
<PAGE>

ITEM # 3

Disclosure Controls and Procedures

   As  of  the  period  covered  by  this  report,  the  Company  carried out an
evaluation,  under the supervision and with the participation of our management,
including  the  Chief  Executive  Officer  and President and the Chief Financial
Officer,  of  the  effectiveness  of  the design and operation of the disclosure
controls and procedures.

    Based  upon this evaluation, our Chief Executive Officer and Chief Financial
Officer  concluded  that,  our disclosure controls and procedures were effective
and  that there were no changes to our Company's internal control over financial
reporting  that  have materially affected, or is reasonably likely to materially
affect the Company's internal control over financial reporting during the period
covered by the Company's quarterly report.

PART II - OTHER INFORMATION

   The Company operates entirely from its sole location at 35 Industrial Parkway
in  Branchburg,  New  Jersey,  an owned facility secured by a mortgage through a
bank.

   The  existing  facility will be adequate for the Company's operations for the
foreseeable future.

ITEM # 6. Exhibits

       Exhibit No.    Description
       -----------    -----------
       31.1           Rule 13a-14(a) Certification  of  Chief  Executive Officer
                        and President
       31.2           Rule 13a-14(a) Certification of Vice  President of Finance
                        and Chief Financial  Officer
       32.1           Section  1350  Certification  of  Chief  Executive Officer
                        and Chairman, President
       32.2           Section 1350 Certification of  Chief Financial Officer and
                        Vice President of Finance

                                   SIGNATURES

Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on his behalf by the
undersigned thereunto duly authorized.

                                                HYDROMER, INC.

                                                /s/ Robert Y. Lee, VP
                                                --------------------
                                                Robert Y. Lee
                                                Principal Accounting Officer &
                                                Chief Financial Officer



DATE: November 9, 2010




















                                       9
<PAGE>
                                  EXHIBIT 31.1

I, Manfred F. Dyck, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hydromer, Inc.;

2.      Based on my knowledge, this quarterly report does not contain any untrue
        statement  of a material fact or omit to state a material fact necessary
        to  make  the statements made, in light of the circumstances under which
        such  statements  were  made,  not misleading with respect to the period
        covered by this quarterly report;

3.      Based  on  my  knowledge,  the financial statements, and other financial
        information  included  in  this  quarterly report, fairly present in all
        material  respects  the  financial  condition, results of operations and
        cash  flows  of  the registrant as of, and for, the periods presented in
        this quarterly report;

4.      The  registrant's  other  certifying officer, Mr. Robert Y. Lee and I am
        responsible  for  establishing  and  maintaining disclosure controls and
        procedures  (as  defined  in Exchange Act Rules 13a-15(e) and 15d-15(e))
        and  internal  control  over financial reporting (as defined in Exchange
        Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

      a) designed  such  disclosure  controls  and  procedures,  or  caused such
         disclosure   controls   and   procedures   to  be  designed  under  our
         supervision,  to  ensure  that  material  information  relating  to the
         registrant,  including  its consolidated subsidiaries, is made known to
         us  by  others within those entities, particularly during the period in
         which this quarterly report is being prepared;

      b) designed  such  internal  controls  over financial reporting, or caused
         such  internal  controls  over financial reporting to be designed under
         our   supervision,  to  provide  reasonable  assurances  regarding  the
         reliability  of  financial  reporting  and the preparation of financial
         statements  for external purposes in accordance with generally accepted
         accounting principles

      c) evaluated the effectiveness of the registrant's disclosure controls and
         procedures  and  presented  in  this  report  our conclusions about the
         effectiveness  of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

      d) disclosed  in  this  report  any  change  in  the registrant's internal
         control  over financial reporting that occurred during the registrant's
         most  recent  fiscal quarter (the registrant's fourth fiscal quarter in
         case  of  an  annual  report)  that  has  materially  affected,  or  is
         reasonably  likely  to  materially  affect,  the  registrant's internal
         control over financial reporting;

5.      The  registrant's other certifying officer, Mr. Robert Y. Lee and I have
        disclosed,  based  on  our  most  recent evaluation, to the registrant's
        auditors  and the audit committee of registrant's board of directors (or
        persons performing the equivalent functions):

      a) all  significant  deficiencies  in  the design or operation of internal
         controls  which  could  adversely  affect  the  registrant's ability to
         record,   process,   summarize  and  report  financial  data  and  have
         identified  for  the  registrant's  auditors any material weaknesses in
         internal controls; and

      b) any  fraud,  whether or not material, that involves management or other
         employees  who  have  a  significant  role in the registrant's internal
         controls; and

6.      The  registrant's other certifying officer, Mr. Robert Y. Lee and I have
        indicated  in  this  quarterly  report  whether  there  were significant
        changes   in   internal   controls   or  in  other  factors  that  could
        significantly  affect  internal  controls  subsequent to the date of our
        most  recent evaluation, including any corrective actions with regard to
        significant deficiencies and material weaknesses.

Date: November 9, 2010

/s/ Manfred F. Dyck
--------------------------------------
Manfred F. Dyck, President and CEO

<PAGE>
                                  EXHIBIT 31.2

I, Robert Y. Lee, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hydromer, Inc.;

2.      Based on my knowledge, this quarterly report does not contain any untrue
        statement  of a material fact or omit to state a material fact necessary
        to  make  the statements made, in light of the circumstances under which
        such  statements  were  made,  not misleading with respect to the period
        covered by this quarterly report;

3.      Based  on  my  knowledge,  the financial statements, and other financial
        information  included  in  this  quarterly report, fairly present in all
        material  respects  the  financial  condition, results of operations and
        cash  flows  of  the registrant as of, and for, the periods presented in
        this quarterly report;

4.      The  registrant's other certifying officer, Mr. Manfred F. Dyck and I am
        responsible  for  establishing  and  maintaining disclosure controls and
        procedures  (as  defined  in Exchange Act Rules 13a-15(e) and 15d-15(e))
        and  internal  control  over financial reporting (as defined in Exchange
        Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

      a) designed  such  disclosure  controls  and  procedures,  or  caused such
         disclosure   controls   and   procedures   to  be  designed  under  our
         supervision,  to  ensure  that  material  information  relating  to the
         registrant,  including  its consolidated subsidiaries, is made known to
         us  by  others within those entities, particularly during the period in
         which this quarterly report is being prepared;

      b) designed  such  internal  controls  over financial reporting, or caused
         such  internal  controls  over financial reporting to be designed under
         our   supervision,  to  provide  reasonable  assurances  regarding  the
         reliability  of  financial  reporting  and the preparation of financial
         statements  for external purposes in accordance with generally accepted
         accounting principles

      c) evaluated the effectiveness of the registrant's disclosure controls and
         procedures  and  presented  in  this  report  our conclusions about the
         effectiveness  of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

      d) disclosed  in  this  report  any  change  in  the registrant's internal
         control  over financial reporting that occurred during the registrant's
         most  recent  fiscal quarter (the registrant's fourth fiscal quarter in
         case  of  an  annual  report)  that  has  materially  affected,  or  is
         reasonably  likely  to  materially  affect,  the  registrant's internal
         control over financial reporting;

5.      The  registrant's  other  certifying  officer, Mr. Manfred F. Dyck and I
        have disclosed, based on our most recent evaluation, to the registrant's
        auditors  and the audit committee of registrant's board of directors (or
        persons performing the equivalent functions):

      a) all  significant  deficiencies  in  the design or operation of internal
         controls  which  could  adversely  affect  the  registrant's ability to
         record,   process,   summarize  and  report  financial  data  and  have
         identified  for  the  registrant's  auditors any material weaknesses in
         internal controls; and

      b) any  fraud,  whether or not material, that involves management or other
         employees  who  have  a  significant  role in the registrant's internal
         controls; and

6.      The  registrant's  other  certifying  officer, Mr. Manfred F. Dyck and I
        have  indicated  in this quarterly report whether there were significant
        changes   in   internal   controls   or  in  other  factors  that  could
        significantly  affect  internal  controls  subsequent to the date of our
        most  recent evaluation, including any corrective actions with regard to
        significant deficiencies and material weaknesses.

Date: November 9, 2010

/s/ Robert Y. Lee,VP
--------------------------------------
Robert Y. Lee, Vice President of Finance and CFO

<PAGE>

                                  EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                      PURSUANT TO 18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I,  Manfred  F.  Dyck,  certify,  pursuant to 18 U.S.C. Section 1350, as adopted
pursuant  to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report  of  Hydromer, Inc. on Form 10-Q for the three months ended September 30,
2010  fully  complies  with  the  requirements  of Section 13(a) or 15(d) of the
Securities  Exchange  Act  of 1934 and that information contained in such report
fairly  presents in all material respects the financial condition and results of
operations of Hydromer, Inc.

Date: November 9, 2010                      By:  /s/ Manfred F. Dyck
                                                   Manfred F. Dyck
                                                   Chairman, President and
                                                   Chief Executive Officer


--------------------------------------------------------------------------------


                                  EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                      PURSUANT TO 18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I,  Robert  Y.  Lee,  certify,  pursuant  to  18 U.S.C. Section 1350, as adopted
pursuant  to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report  of  Hydromer, Inc. on Form 10-Q for the three months ended September 30,
2010  fully  complies  with  the  requirements  of Section 13(a) or 15(d) of the
Securities  Exchange  Act  of 1934 and that information contained in such report
fairly  presents in all material respects the financial condition and results of
operations of Hydromer, Inc.

Date: November 9, 2010                      By: /s/ Robert Y. Lee,VP
                                                 Robert Y. Lee
                                                 Chief Financial Officer and
                                                 Vice President of Finance